Structure-Guided Drug Firmonertinib Delivers Durable Responses in EGFR PACC-Mutated Lung Cancer
The concept of grouping EGFR mutations by structural rather than purely positional criteria represents a meaningful shift in how oncologists ...
Tag: Firmonertinib
Double-Dose Firmonertinib Boosts EGFR L858R Lung Cancer Treatment
A groundbreaking advancement in the fight against non-small-cell lung cancer (NSCLC) has emerged from a recent multicenter phase II study ...
POPULAR NEWS
-
Vasopressors Exert Divergent Immunomodulatory Effects Across a Spectrum in Septic Shock
-
Study Identifies Key Drivers Shaping Salmonid Gill Microbiomes in Aquaculture
-
Chinese Cancer Association issues unified guideline for tumor-related lung injury care
-
Modeling Reveals How Silica Gold Nanoparticles Reshape Optical Energy and Fields